CRISPR Therapeutics is targeting multiple difficult-to-treat diseases with several candidates.
Forget AI Stocks: This Biotech Could Cure What AI Can’t Touch
CRISPR Therapeutics is targeting multiple difficult-to-treat diseases with several candidates.